Polygenic embryo screening: are there potential maternal and fetal harms?

Perrine Ginod,Michael H Dahan,Michael H. Dahan
DOI: https://doi.org/10.1016/j.rbmo.2023.103327
IF: 4.567
2023-08-08
Reproductive BioMedicine Online
Abstract:Polygenic embryo screening (PES) and its derivate the Embryo Health Score (EHS) has generated interest in both infertile and fertile populations due to its potential ability to select embryos with a reduced risk of disease and improved long-term health outcomes. Concerns have been raised regarding the potential harms: of the in vitro fertilization (IVF) itself and the manipulation of epigenetic factors in the IVF laboratory possibly affecting the offsprings' health in late adulthood, which are not fully captured in the EHS calculation. The knowledge of the potential impacts of the trophectoderm biopsy (TEB) on the offsprings' health, a key component of PES, is limited by the heterogeneity in the population characteristics used in the published studies. Nonetheless, the literature suggests a possible increased risk of preterm delivery, birth defects, and preeclampsia after TEB. Overall, the risks of PES on prenatal and postnatal health remain uncertain, and further research is needed. Counselling with patients regarding these risks before considering PES is important, to provide an understanding of the risks and the benefits. This review aims to highlight some of these issues, the need for continued investigation in this area, and the importance of informed decision-making in the context of PES.
obstetrics & gynecology,reproductive biology
What problem does this paper attempt to address?